Seminari VHIR - Dr. Dr. Francesco Piraino "Monitoring Health and Disease Progression with Utrasensitive Biomarker Analysis"

 
  Sala d'Actes, planta baixa. Hospital General —
12/02/2019
12/02/2019 -- From 15:30h to 17:00h
Organize :
Vall d'Hebron Institut de Recerca
Modality: Presencial
Share it:

Dr. Francesco Piraino, Scientist Bioengineer - Quanterix, Inc,

"Monitoring Health and Disease Progression with Utrasensitive Biomarker Analysis"

Quanterix Simoa™ technology detects proteins with 1000]fold higher sensitivity than traditional immunoassays

ltrasensitive detection is enabling the identification of more informative biomarkers requiring less invasive and less expensive testing procedures
to improve our understanding of neurodegenerative disease.
Simoa assays are currently applied across various therapeutic areas including neurology, oncology, cardiology, inflammation and infectious
disease to detect biomarkers in a variety of sample matrices.
Quanterix cytokine assays lead the field with respect to precision, disease correlation and detection of endogenous analytes.Quanterix offers a large menu of commercially available assays, an open instrument platform for developing homebrew assays, and assay testing services.

BIO: Francesco Piraino is a research scientist at the Swiss Federal Institute of Technology in Lausanne (Switzerland). He uses microscale technologies to develop next-generation microfluidic diagnostics platforms. Following his graduate studies in Biomedical Engineering at Politecnico di Milano (Italy) and at Harvard-MIT Division of Health Science & Technology (USA), he joined the Broad Institute of MIT and Harvard (USA) to develop devices for single-cell genomics. Dr. Piraino is a trained bioengineer who has also attended programs at the Universitat de Barcelona (Spain), the City
College of the City University of New York (USA), and the Massachusetts Institute of Technology (USA). His work aims to solve problems at the intersection of biomedical engineering and medicine.

Host: Clinical Neuroimmunology,  manuel.comabella@vhir.org

 

Subscribe to our newsletters and be a part of Campus Life

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vhebron.net, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.